EHTI explains how payers and providers should take up innovative technology
This article was originally published in Clinica
Executive Summary
Companies should engage with Health Technology Assessment (HTA) bodies and constructively criticise their methods when examining the value of medical technology in healthcare. Passive acceptance of their methodologies will risk inappropriate rejection of new technologies that could offer significant value for healthcare systems.